Here, we report our findings of additional recurrent and novel founder variants in the NDRG1 gene identified in Bulgarian CMT1 patients and provide functional evidence on the pathogenicity of novel splice-site variants in the gene in non-Roma patients. The gene discussed is NDRG1; the disease is Charcot-Marie-Tooth disease type 1.